secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2025-12-01T23:59:59+00:00
Accession:  0001553350-25-000168
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Board member Gabe Ling resigns from The Oncology Institute board effective Dec 1, 2025
--------------------------------------------------------------------------------

- Gabriel Ling resigned from the Board of Directors, effective December 1, 2025, with no disagreement with the company.
- Chairman Anne McGeorge thanked Ling for his service during TOI's early years as a public company.
- Formal search initiated for new independent directors with healthcare, clinical, and value-based care expertise.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000155335025000168/0001553350-25-000168-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000155335025000168/toi_8k.htm
  HTML page:      https://secwatch.observer/filing/0001553350-25-000168

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer